News


 CIBS2025 Sales Officially Launched: Revitalization of new life

CIBS2025 Sales Officially Launched: Revitalization of new life

July 08, 2024 07:30 PM AEST| By Cision

SHANGHAI, July 8, 2024 /PRNewswire/ -- Reviewing CIBS2024, the show covered an exhibition area of 45,000 square meters, with more than 600 high-quality brands and exhibitors making a grand appearance,...

 Dollar stabilizes ahead of key inflation data; euro gains

Dollar stabilizes ahead of key inflation data; euro gains

July 08, 2024 07:28 PM AEST| By Investing

 Connect Neo Garden with Chinese Consumers using XiaoHongShu

Connect Neo Garden with Chinese Consumers using XiaoHongShu

July 08, 2024 07:28 PM AEST| By Cision

SINGAPORE, July 8, 2024 /PRNewswire/ -- In Singapore's dynamic catering industry, Neo Garden, a leader under Neo Group Limited, sought to expand its client base and boost sales for its catering and Ti...

 DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease

DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease

July 08, 2024 07:23 PM AEST| By Cision

BEIJING, July 8, 2024 /PRNewswire/ -- DP Technology, an "AI for Science" paradigm-driven company, today announced the nomination of DPT0416, a novel CNS penetrable small molecule targeting L...

 MGI Tech Partners with Australian Research Council Training Centre CEAStAR to Lead Innovation in Antimicrobial Resistance Solutions

MGI Tech Partners with Australian Research Council Training Centre CEAStAR to Lead Innovation in Antimicrobial Resistance Solutions

July 08, 2024 07:14 PM AEST| By Cision

BRISBANE, Australia, July 8, 2024 /PRNewswire/ -- MGI Australia Pty Ltd, subsidiary of MGI Tech Co., Ltd., a company committed to building core tools and technologies that drive innovation in l...

 Vantage Markets elevates Copy Trading with Multi-Currency and Multi-Account Type support

Vantage Markets elevates Copy Trading with Multi-Currency and Multi-Account Type support

July 08, 2024 07:05 PM AEST| By Cision

PORT VILA, Vanuatu, July 8, 2024 /PRNewswire/ -- Leading multi-asset broker, Vantage Markets (Vantage), is thrilled to announce a series of exciting enhancements to its Vantage App, aimed...

 Crude Rallies as Geopolitical Tensions and Lower Inventories Lift Sentiment, ANZ Bank Says

Crude Rallies as Geopolitical Tensions and Lower Inventories Lift Sentiment, ANZ Bank Says

July 08, 2024 07:04 PM AEST| By EODHD

Crude Rallies as Geopolitical Tensions and Lower Inventories Lift Sentiment, ANZ Bank Says

 DPC Dash - Domino's Pizza China Concludes First Half of 2024 with Sustained Expansion and Innovation

DPC Dash - Domino's Pizza China Concludes First Half of 2024 with Sustained Expansion and Innovation

July 08, 2024 07:04 PM AEST| By Cision

HONG KONG, July 8, 2024 /PRNewswire/ -- DPC Dash – Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), Domino's Pizza's exclusive master franchisee in the China Ma...

 Uxin Announces Strategic Partnership with Zhengzhou Airport Industry

Uxin Announces Strategic Partnership with Zhengzhou Airport Industry

July 08, 2024 07:02 PM AEST| By Cision

BEIJING, July 8, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company", together with its subsidiaries, the "Group") (Nasdaq: UXIN), China's leading used car retaile...

 DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME

July 08, 2024 07:00 PM AEST| By Cision

The nomination of novel Lp-PLA2 inhibitor DPT0415 for the treatment of DR & DME. DPT0415 is a highly potent, selective and safe Lp-PLA2 inhibitor with sufficient target engagement at a dose...

 Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors

Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors

July 08, 2024 06:28 PM AEST| By Cision

MORRISVILLE, NC., July 8, 2024 /PRNewswire/ -- Immorna Biotherapeutics, Inc. (Immorna), a clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics...

 ESGRI Launches Free ESG Benchmarking Tool to Evaluate Businesses’ ESG Performance

ESGRI Launches Free ESG Benchmarking Tool to Evaluate Businesses’ ESG Performance

July 08, 2024 06:17 PM AEST| By EIN Presswire

ESGRI Logo ESG Rating for Business Free ESG Health Check ESG Reporting Intelligence launches a FREE ESG health check to provide businesses with a clear understanding of how to prepare for mandatory ES...

 Copenhagen launches new green experience economy initiative, CopenPay

Copenhagen launches new green experience economy initiative, CopenPay

July 08, 2024 06:00 PM AEST| By Cision

COPENHAGEN, Denmark, July 8, 2024 /PRNewswire/ -- To get tourists to act more sustainably Wonderful Copenhagen is launching a new initiative: Pay for a variety of Copenhagen attractions wi...

 Discovering happiness: A romantic journey in Qingyuan

Discovering happiness: A romantic journey in Qingyuan

July 08, 2024 05:55 PM AEST| By Cision

GUANGZHOU, China, July 8, 2024 /PRNewswire/ -- News report from GDToday.  Join us on a heartwarming adventure in Qingyuan, where love and happiness fill the air. In this vlog, we follow 100 n...

 Advancing Its Plan Towards Net Zero, Vinamilk Announces Third Carbon Neutral Facility

Advancing Its Plan Towards Net Zero, Vinamilk Announces Third Carbon Neutral Facility

July 08, 2024 05:44 PM AEST| By Cision

HO CHI MINH CITY, Vietnam, July 8, 2024 /PRNewswire/ -- Vinamilk, Vietnam's leading dairy company, announce that its Vietnam Beverage Factory has attained international certification for Carbon Neutra...

 King River Resources (ASX: KRR) shares jump on latest payment in Speewah deal

King River Resources (ASX: KRR) shares jump on latest payment in Speewah deal

July 08, 2024 05:18 PM AEST| By Sonal Goyal

Highlights,King River Resources received AU$1.6 million in cash from Tivan for the acquisition of the Speewah Project.,An outstanding balance of AU$2.4 million is due by 17 February 2025.,As of 8 July 2024, KRR's cash position was AU$5.28 million.,Sh...

 Mainland China-Hong Kong ETF Connect Marks Two Years of Strengthened Market Integration, Expansion Expected to Boost Investment Options and Liquidity

Mainland China-Hong Kong ETF Connect Marks Two Years of Strengthened Market Integration, Expansion Expected to Boost Investment Options and Liquidity

July 08, 2024 05:14 PM AEST| By Cision

GUANGZHOU, China, July 8, 2024 /PRNewswire/ -- On July 4th, the ETF Connect Program, which facilitated two way capital flows between mainland China and Hong Kong for eligible ETFs, celebrated i...

 8849 Tank 3S: a Revolutionary DLP Projector Smartphone with Android 14

8849 Tank 3S: a Revolutionary DLP Projector Smartphone with Android 14

July 08, 2024 05:00 PM AEST| By Cision

SHENZHEN, China, July 8, 2024 /PRNewswire/ -- 8849, a pioneering rugged electronic devices brand, announced today the global launch of its latest innovation, the 8849 Tank 3S. Packed with cutting-edge...

 Above the Sky: Sino Jet Partners with Kaluga Queen Caviar to Lead a Life of Exquisite Elegance

Above the Sky: Sino Jet Partners with Kaluga Queen Caviar to Lead a Life of Exquisite Elegance

July 08, 2024 04:46 PM AEST| By Cision

HONG KONG, July 8, 2024 /PRNewswire/ -- Sino Jet, with its unwavering commitment to quality and unparalleled living experiences, meticulously curates and fervently shares exceptional brands and...

 Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics

Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics

July 08, 2024 04:30 PM AEST| By Cision

HONG KONG and GERMANTOWN, Md. and SUZHOU, China, July 8, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaom...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.